Dewpoint Therapeutics Teams Up with Merck to Evaluate Novel Approach for the Treatment of HIV World Business July 14, 2020 Dewpoint Therapeutics, the biomolecular condensates company, announced today that it has forged an exclusive collaboration agreement with Merck (NYSE:MRK), known…
